TI
GNMK

Trexquant Investment’s GenMark Diagnostics, Inc GNMK Stock Holding History

Trexquant Investment’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-39,720
Closed -$564K – 1656
2020
Q3 		$564K Sell
39,720
-28,497
-42% -$435K 0.04% 629
2020
Q2 		$1M Buy
+68,217
New +$693K 0.07% 399
2019
Q4 		– Sell
-11,052
Closed -$67K – 1349
2019
Q3 		$67K Buy
+11,052
New +$69K 0.01% 817
2017
Q4 		– Sell
-15,696
Closed -$151K – 1327
2017
Q3 		$151K Sell
15,696
-15,690
-50% -$163K 0.04% 687
2017
Q2 		$371K Buy
+31,386
New +$401K 0.1% 361

Other funds holding GNMK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Trexquant Investment's GNMK Position: Q4 2020 in Review

Trexquant Investment sold out of GenMark Diagnostics, Inc (GNMK) in Q4 2020, closing a stake of 39,720 shares — an estimated $564K sold.

Trexquant Investment first reported a position in GNMK in Q2 2017 and held it in 5 quarters. The position peaked at $1M in Q2 2020. 151 funds tracked by Wall St. Rank hold GNMK as of Q4 2020.

  • Trexquant Investment reported no remaining GenMark Diagnostics, Inc position as of Q4 2020 after selling out during the quarter.
  • Trexquant Investment sold 39,720 GenMark Diagnostics, Inc shares in Q4 2020, an estimated $564K.
  • Trexquant Investment first reported a position in GenMark Diagnostics, Inc in Q2 2017 and held it in 5 quarters.
  • Trexquant Investment's GenMark Diagnostics, Inc position peaked at $1M in Q2 2020.
  • 151 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q4 2020.

Based on Trexquant Investment's 13F filing for Q4 2020, filed 11 Feb 2021.